Oct 2019 $21 M No. 8 $10 to $50 million 3
Cherrypharm Inc.: Raise no. 8, Oct 2019 × Investors in this round 3 investors had bought by the notice of Jun 26, 2020: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $21 M of $32 M offered; $11 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $175,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Ben Fineberg · Executive Officer Mike Hagan · Executive Officer Andreas Guldin · Director Marcel Bens · Director Morgan Ratcliffe · Director Zachary Shulman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mike Hagan, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 26, 2020. Read the notice at the SEC .
equity, options SEC Mar 2018 $10 M No. 7 $10 to $50 million 43
Cherrypharm Inc.: Raise no. 7, Mar 2018 × Investors in this round 43 investors had bought by the notice of Aug 9, 2018: 43 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $17 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $300,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees as estimates
The company Corporation, incorporated in Delaware People named in the notice Bill Brophy · Executive Officer Mike Hagan · Executive Officer Steven Pear · Executive Officer, Director Andreas Guldin · Director John Shields · Director Michael Oringer · Director Scott Roman · Director Thomas Facer · Director Zachary Shulman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Steven Pear, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Aug 9, 2018. Read the notice at the SEC .
debt, options SEC Mar 2018 $5 M No. 6 $2 to $10 million 11
Cherrypharm Inc.: Raise no. 6, Mar 2018 × Investors in this round 11 investors had bought by the notice of Mar 20, 2018: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $12 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $300,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees as estimates
The company Corporation, incorporated in Delaware People named in the notice Bill Brophy · Executive Officer Mike Hagan · Executive Officer Steven Pear · Executive Officer, Director Andreas Guldin · Director John Shields · Director Michael Oringer · Director Scott Roman · Director Thomas Facer · Director Zachary Shulman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Steven Pear, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 20, 2018. Read the notice at the SEC .
debt, options SEC Mar 2016 $5 M No. 5 $2 to $10 million 12
Cherrypharm Inc.: Raise no. 5, Mar 2016 × Investors in this round 12 investors had bought by the notice of Nov 2, 2017: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $10 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $500,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice James O'Callaghan · Executive Officer Mike Hagan · Executive Officer Stephen Pear · Executive Officer, Director Andreas Guldin · Director Hans Heer · Director John Shields · Director Michael Oringer · Director Thomas Facer · Director Zachary Shulman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Steven Pear, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Nov 2, 2017. Read the notice at the SEC .
equity, options SEC Nov 2014 $2 M No. 4 Under $2 million 2
Cherrypharm Inc.: Raise no. 4, Nov 2014 × Investors in this round 2 investors had bought by the notice of Dec 3, 2014: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Edmund Maguire · Executive Officer Stephen Pear · Executive Officer, Director Andreas Guldin · Director Hans Heer · Director John Shields · Director Michael Oringer · Director Thomas Facer · Director Zachary Shulman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Edmund Maguire, Vice President and Secretary. Source: SEC Form D, newest notice filed Dec 3, 2014. Read the notice at the SEC .
equity, options SEC Nov 2013 $1 M No. 3 Under $2 million 5
Cherrypharm Inc.: Raise no. 3, Nov 2013 × Investors in this round 5 investors had bought by the notice of Apr 2, 2014: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken $10,000
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Brian Ross · Executive Officer, Director, Promoter Edmund Maguire · Executive Officer Andreas Guldin · Director Hans Heer · Director John Shields · Director Michael Oringer · Director Thomas Facer · Director Zachary Shulman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Edmund Maguire, Vice President and Secretary. Source: SEC Form D, newest notice filed Apr 2, 2014. Read the notice at the SEC .
debt, options SEC Feb 2012 $5 M No. 2 $2 to $10 million 32
Cherrypharm Inc.: Raise no. 2, Feb 2012 × Investors in this round 32 investors had bought by the notice of Feb 21, 2012: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Brian Ross · Executive Officer, Director Brittany Ridley · Executive Officer Andreas J. Guldin · Director John Shields · Director Thomas J. Facer · Director William J. Weiland · Director Zachary J. Shulman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Brian Ross, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 21, 2012. Read the notice at the SEC .
equity SEC Aug 2009 $2 M No. 1 Under $2 million 32
Cherrypharm Inc.: Raise no. 1, Aug 2009 × Investors in this round 32 investors had bought by the notice of Jan 21, 2010: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Carol P. Langdon · Executive Officer · Treasurer and Secretary Donald S. Copland · Director, Executive Officer · President and Chief Executive Officer Christopher L. Shoemaker · Director Thomas A. Facer · Director Thomas P. Burnet · Director Zachary L. Shulman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Offering closed in December 2009 - no further amount will be sold.”On the use of proceeds: “$50,000 of proceeds were paid to a former director at the time of the initial offering and who has since resigned as a director.”Signed by Donald S. Copland, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 21, 2010. Read the notice at the SEC .
equity SEC